logo

Alexion Pharmaceuticals Inc. (ALXN)



Trade ALXN now with
  Date
  Headline
9/14/2017 4:32:50 PM Alexion Adds Paul Friedman To Its Board Of Directors
9/12/2017 8:04:19 AM Alexion Plans Restructuring To Reduce Global Workforce By Approximately 20%
8/21/2017 9:26:09 AM Alexion Says EC Approved Extension Of Indication For Soliris (eculizumab)
8/10/2017 6:32:08 AM Alexion Pharma And Sema4 Partner In Rare Disease Diagnostics And Systems Biology
7/27/2017 6:44:21 AM Alexion Pharmaceuticals Inc. (ALXN) Has Raised Its FY17 Revenue Estimate To $3.450 - $3.525 Bln From $3.400 - $3.500 Bln
7/27/2017 6:43:33 AM Alexion Pharmaceuticals Inc. (ALXN) Has Raised Its FY17 EPS Estimate To 5.40 - 5.55 From 5.10 - 5.30
7/27/2017 6:31:19 AM Alexion Pharma Q2 Non-GAAP EPS $1.56 Vs $1.13 Last Year
7/5/2017 4:04:55 AM Alexion Reaches Funding Agreement With NICE And NHS England For Strensiq
6/23/2017 8:01:05 AM Alexion Gets Positive CHMP Opinion For Soliris For Patients With Refractory Generalized Myasthenia Gravis